Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer

2018164 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT01983501.

Good health and well-being

Published in: JAMA Oncology

Volume 4, Issue 9, pp. 1214-1214

Field-Weighted Citation Impact: 6.24